Related references
Note: Only part of the references are listed.Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease
Georg Semmler et al.
HEPATOLOGY (2021)
Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery
Patrick Starlinger et al.
HEPATOLOGY (2021)
Acute kidney injury is associate d with increase d levels of circulating microvesicles in patients with decompensated cirrhosis
Elena Campello et al.
DIGESTIVE AND LIVER DISEASE (2021)
Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure-Related Bleeding in Decompensated Cirrhosis
Alberto Zanetto et al.
HEPATOLOGY COMMUNICATIONS (2021)
Assessment of peripheral endothelial function predicts future risk of solid-tumor cancer
Takumi Toya et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis
Maxime G. Zermatten et al.
HEPATOLOGY (2020)
Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
Sangdeok Shin et al.
MEDICINE (2020)
Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection
Teng-Yu Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Tracey G. Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features
Alberto Zanetto et al.
HEPATOLOGY (2020)
Von Willebrand factor and cancer; metastasis and coagulopathies
Sean Patmore et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma
Po-Hong Liu et al.
LIVER INTERNATIONAL (2020)
Endothelial Damage of the Portal Vein is Associated with Heparin-Like Effect in Advanced Stages of Cirrhosis
Sarah Shalaby et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling
Antonio Giovanni Solimando et al.
CANCERS (2020)
von Willebrand factor promotes platelet-induced metastasis of osteosarcoma through activation of the VWF-GPIb axis
Q. Wang et al.
JOURNAL OF BONE ONCOLOGY (2020)
Pre-surgical level of von Willebrand factor as an evident indicator of breast cancer recurrence
Piotr Rhone et al.
CANCER BIOMARKERS (2020)
Whole-blood hypocoagulable profile correlates with a greater risk of death within 28 days in patients with severe sepsis
Annalisa Boscolo et al.
KOREAN JOURNAL OF ANESTHESIOLOGY (2020)
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Mohsen Malehmir et al.
NATURE MEDICINE (2019)
Bivalent property of intra-platelet VWF in liver regeneration and HCC recurrence: A prospective multicenter study
Bibek Aryal et al.
CANCER BIOMARKERS (2019)
Platelets as Key Factors in Hepatocellular Carcinoma
Natasa Pavlovic et al.
CANCERS (2019)
Platelet activation status in the diagnosis and postoperative prognosis of hepatocellular carcinoma
Beili Wang et al.
CLINICA CHIMICA ACTA (2019)
The role of coagulation and platelets in colon cancer-associated thrombosis
Annachiara Mitrugno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics
Quirino Lai et al.
CANCERS (2019)
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis
Stefaia Basin et al.
HEPATOLOGY COMMUNICATIONS (2019)
Emerging Roles for von Willebrand Factor in Cancer Cell Biology
Jamie M. O'Sullivan et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals
Francesco Paolo Russo et al.
LIVER INTERNATIONAL (2018)
Cancer cell-derived von Willebrand factor enhanced metastasis of gastric adenocarcinoma
Ai-jun Yang et al.
ONCOGENESIS (2018)
Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma
Patrizia Burra et al.
CANCERS (2018)
The prognostic role of pretreatment thrombocytosis in gastric cancer A systematic review and meta-analysis
Chen Yang et al.
MEDICINE (2018)
Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients
Claudio Belluco et al.
BMC CANCER (2018)
The Cirrhotic Platelet: Shedding Light on an Enigma
Stephen Caldwell et al.
HEPATOLOGY (2017)
Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis, and Management: 2016 Practice Guidance by the American Association for the Study of Liver Diseases
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2017)
Low-Grade Endotoxemia and Platelet Activation in Cirrhosis
Valeria Raparelli et al.
HEPATOLOGY (2017)
Thrombocytopenia in chronic liver disease
Markus Peck-Radosavljevic
LIVER INTERNATIONAL (2017)
Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin
Anahita Mojiri et al.
ONCOTARGET (2017)
Antiplatelet Therapy and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Antiviral Treatment
Minjong Lee et al.
HEPATOLOGY (2017)
Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans
Robin Padickakudy et al.
JOURNAL OF HEPATOLOGY (2017)
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma
Alberto Zanetto et al.
DIGESTIVE AND LIVER DISEASE (2017)
Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences
Soraya Mezouar et al.
THROMBOSIS RESEARCH (2016)
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis
Elena Campello et al.
THROMBOSIS RESEARCH (2016)
Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding
Rongfeng Zhang et al.
ONCOTARGET (2016)
Platelets at the interface of thrombosis, inflammation, and cancer
Aime T. Franco et al.
BLOOD (2015)
Hypercoagulability detected by whole blood thromboelastometry (ROTEM®) and impedance aggregometry (MULTIPLATE®) in obese patients
Elena Campello et al.
THROMBOSIS RESEARCH (2015)
No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma
Edris M. Alkozai et al.
THROMBOSIS RESEARCH (2015)
Active von Willebrand factor predicts 28-day mortality in patients with systemic inflammatory response syndrome
Agon Hyseni et al.
BLOOD (2014)
von Willebrand factor, Jedi knight of the bloodstream
Timothy A. Springer
BLOOD (2014)
Platelets Effects on Tumor Growth
Hadi A. Goubran et al.
SEMINARS IN ONCOLOGY (2014)
Platelet-Derived Nucleotides Promote Tumor-Cell Transendothelial Migration and Metastasis via P2Y2 Receptor
Dagmar Schumacher et al.
CANCER CELL (2013)
Coagulation and cancer: biological and clinical aspects
A. Falanga et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Platelets increase the proliferation of ovarian cancer cells
Min Soon Cho et al.
BLOOD (2012)
Paraneoplastic Thrombocytosis in Ovarian Cancer
Rebecca L. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
Giovanni Sitia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension
Vincenzo La Mura et al.
GUT (2011)
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
F. Violi et al.
JOURNAL OF HEPATOLOGY (2011)
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
R. Simanek et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma
Christian Toso et al.
LIVER TRANSPLANTATION (2008)
Angiogenesis is regulated by a novel mechanism:: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released
Joseph E. Italiano et al.
BLOOD (2008)
Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity
T Lisman et al.
HEPATOLOGY (2006)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Thrombocytosis: A paraneoplastic syndrome in patients with hepatocellular carcinoma
Shinn-Jang Hwang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)